Learn about support and programs that may help you pay for GILOTRIF.

What you should know about lung cancer

A diagnosis of advanced (metastatic) non-small cell lung cancer (NSCLC) can be difficult and overwhelming for both you and your family. It is, however, important to keep positive and hopeful. You are not alone. Lung cancer is one of the most common of all cancers. And among the different types of lung cancer, NSCLC is the most common. With so many people affected by advanced NSCLC, the medical and research communities are working extremely hard to help the many people like you.


GILOTRIF is a prescription medicine used to treat people with non-small cell lung cancer (NSCLC):

• that has certain types of abnormal epidermal growth factor receptor (EGFR) genes. Your doctor will perform a test to check for certain types of abnormal EGFR genes, and make sure that GILOTRIF is right for you. GILOTRIF may be used when you have not had previous treatment for cancer that has spread to other parts of the body. It is not known if GILOTRIF is safe and effective in treating lung cancer with other abnormal EGFR genes.


• that is squamous type and has spread to other parts of the body after you have tried chemotherapy that contains platinum.

It is not known if GILOTRIF is safe and effective in children.

Find out about NSCLC

Understanding biomarker testing and EGFR mutations

Learn how NSCLC is treated